| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |